Standout Papers

Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 2021 2026 2022 2024289
  1. Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis (2021)
    Maria Pia Sormani, Nicola De Rossi et al. Annals of Neurology

Immediate Impact

52 standout
Sub-graph 1 of 23

Citing Papers

The pathophysiology of sepsis and precision-medicine-based immunotherapy
2024 Standout
Inflammatory Processes in Alzheimer’s Disease—Pathomechanism, Diagnosis and Treatment: A Review
2023 Standout
2 intermediate papers

Works of Paolo Immovilli being referenced

Kappa Index versus CSF Oligoclonal Bands in Predicting Multiple Sclerosis and Infectious/Inflammatory CNS Disorders
2020
Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients
2020

Author Peers

Author Last Decade Papers Cites
Paolo Immovilli 365 364 76 379 44 801
Derrick Robertson 228 439 130 163 45 771
Curtis Offiah 211 317 105 110 31 922
Takashi Ichiyama 174 89 254 331 48 927
Shitiz Sriwastava 460 174 29 247 57 680
Natalia Mena‐Vázquez 217 105 108 275 81 934
Hesham Abboud 563 439 47 157 56 835
M. Maurelli 324 72 54 529 45 885
Ricardo Alonso 150 334 117 70 80 660
Jussi Sipilä 292 114 159 115 70 983
C.F. Andreula 132 341 101 84 50 912

All Works

Loading papers...

Rankless by CCL
2026